BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brooker SM, Edamakanti CR, Akasha SM, Kuo SH, Opal P. Spinocerebellar ataxia clinical trials: opportunities and challenges. Ann Clin Transl Neurol 2021;8:1543-56. [PMID: 34019331 DOI: 10.1002/acn3.51370] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Ru D, Li J, Xie O, Peng L, Jiang H, Qiu R. Explainable artificial intelligence based on feature optimization for age at onset prediction of spinocerebellar ataxia type 3. Front Neuroinform 2022;16:978630. [DOI: 10.3389/fninf.2022.978630] [Reference Citation Analysis]
2 Eisenstein SA, Boodram RS, Sutphen CL, Lugar HM, Gordon BA, Marshall BA, Urano F, Fagan AM, Hershey T. Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome. Front Neurosci 2022;16:795317. [DOI: 10.3389/fnins.2022.795317] [Reference Citation Analysis]
3 Vázquez-Mojena Y, León-Arcia K, González-Zaldivar Y, Rodríguez-Labrada R, Velázquez-Pérez L. Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives. Mov Disord 2021. [PMID: 34628681 DOI: 10.1002/mds.28819] [Cited by in F6Publishing: 3] [Reference Citation Analysis]